Companies: 10,795·Total market cap: $144.5T
Veradigm Inc.

Veradigm Inc.

MDRXOTCHealthcare● Active
$4.58
$-0.42(-8.45%)
Market Cap$777396825
P/E Ratio
52W High$6
52W Low$3

Veradigm Inc. (MDRX) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

mdrx · stock forecast · 43 analysts (3M) · FMP · updated Jun 9, 2026

Analyst Rating & Consensus

Based on 43 Wall Street analysts in the past 3 months

SellBuy

Hold

43 analysts

consensus

Rating Breakdown

Strong Buy
1
Buy
15
Hold
24
Sell
2
Strong Sell
1
Total: 43 · Buy rate: 37.2%

12-Month Price Target

High

$20.00

Consensus

$16.17

+217.1% upside

Low

$10.00

Median: $18.5 · Last Close: $5.10

The Veradigm Inc. (MDRX) analyst consensus is Hold, based on ratings from 43 Wall Street analysts over the past 3 months. The average 12-month MDRX price target is $16.17, representing +217.1% upside from the current price of $5.10.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $16 (217.1%)

Consensus Target

$16.17

217.1% upside

High Target

$20

292.2%

Low Target

$10

96.1%

Current Price

$5.10

as of today

Based on analyst price targets, the MDRX stock price prediction for the next 12 months ranges from $10 to $20. The consensus MDRX price forecast of $16.17 implies 217.1% upside from the current price of $5.10.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-10$5.140.80%

1-day model range: $5.1–$5.18. Peak: $5.18 (+0.80%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$4-16.5%
2028$4-24.1%
2029$4-27.9%
2030$4-29.9%
2031-31.0%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

93%7%0%
13Buy
1Neutral
0Sell
RSI (14)52.8Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · MDRX · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$4.89BUY
MA 10$4.89BUY
MA 20$4.83BUY
MA 50$4.64BUY
MA 100$4.62BUY
MA 200$4.69BUY
Current $MDRX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$4.98BUY
EMA 10$4.91BUY
EMA 20$4.84BUY
EMA 50$4.72BUY
EMA 100$4.68BUY
EMA 200$4.83BUY
Current $MDRX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Stephens & Co.2025-01-31
Maintains
Equal WeightEqual Weight
TD Cowen2024-05-28
Maintains
BuyBuy
Deutsche Bank2024-03-19
Downgrade ↓
BuyHold
RBC Capital2024-01-19
Maintains
OutperformOutperform
Stephens & Co.2023-11-14
Maintains
Equal WeightEqual Weight
Stephens & Co.2023-10-10
Maintains
Equal WeightEqual Weight
Argus Research2023-07-06
Downgrade ↓
BuyHold
Piper Sandler2023-02-01
Downgrade ↓
OverweightNeutral
Argus Research2022-12-07
Upgrade ↑
HoldBuy
JP Morgan2022-11-18
Maintains
UnderweightUnderweight

Wall Street analysts have recently issued updated ratings on Veradigm Inc. (MDRX) stock. Of the recent 162 rating actions, 35 were upgrades and 41 were downgrades. 43 analysts currently cover MDRX.

Analyst Recommendation Trends

Buy ratings00
Hold ratings11
Sell ratings00

MDRX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$585M

↓ 7.1% YoY

Revenue Next Year

$597M

↑ 2.0% YoY

EPS This Year

$0.30

EPS Next Year

$0.39

↑ 26.2% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast MDRX EPS of $0.30 for the current fiscal year, based on estimates from 1 analysts. The MDRX revenue forecast is $585M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The MDRX stock forecast is supported by two independent data sources: analyst consensus ratings from 43 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus MDRX price target is $16.17 (+217.1% upside), with an analyst consensus of Hold.

The MDRX short-term stock prediction for tomorrow is $5.14 (+0.80%). The MDRX stock price prediction for 2027 estimates an average of $4. The MDRX stock prediction for 2030 projects a range of $3–$4.

Veradigm Inc. trades on OTC under the ticker MDRX. The MDRX stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 37% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

MDRX forecast · 8 questions

According to 43 Wall Street analysts, the average 12-month MDRX price target is $16.17, with a high forecast of $20.00 and a low of $10.00. The median price target is shown in the chart above when available. This implies +217.1% potential upside from the current price of $5.10.

MDRX price targetWhat is MDRX price targetMDRX analyst price targetMDRX 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.